CEimpact Podcast

CEimpact
  • 0.0 (0)
  • COURSES
  • UPDATED WEEKLY

The CEimpact Podcast features two shows:  GameChangers Clinical Updates  Precept2Practice GameChangers Clinical Update Series: The GameChangers podcast, hosted by Rachel Maynard, PharmD, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Listeners can purchase the episode to earn CE credit at: https://www.ceimpact.com/resources/podcast/  Precept2PracticeThe Precept2Practice podcast, hosted by Kathy Schott, brings you tools to mentor students and residents with confidence.  New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.Give us a follow, tune in regularly, and turn your drive time, coffee break, or chart review into a chance to level up your practice. CEimpact continuing education makes pharmacy learning inspiring!  Check back each week for our latest episodes. 

  1. Hypertension Updates Every Pharmacist Should Know

    3 DAYS AGO

    Hypertension Updates Every Pharmacist Should Know

    Advancements in hypertension management are shifting the landscape of treatment, from new guideline recommendations to technological innovations. This course explores key highlights from the AHA's recent scientific statements, including single-pill combination therapy and the clinical limitations of some blood pressure devices, alongside updates to the 2025 hypertension guidelines. You will gain a clear understanding of how these changes affect patient care, medication strategies, and pharmacist-driven interventions. Recent ACC/AHA Cholesterol Guidelines further emphasize comprehensive cardiovascular risk assessment and evidence-based management of dyslipidemia alongside other major risk factors such as hypertension. These updates complement the hypertension topics discussed in this episode by reinforcing the importance of coordinated, risk-based approaches to reducing cardiovascular disease. This resource provides a concise, guideline-based overview of hypertension management, summarizing the 2025 ACC/AHA recommendations for blood pressure classification, treatment goals, and stepwise pharmacotherapy. It highlights first- and second-line antihypertensive options, emphasizes individualized, risk-based treatment decisions, and outlines practical considerations for therapy initiation, intensification, and monitoring to optimize cardiovascular outcomes. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Tomasz Jurga,  PharmD, BCPS, BCACP, BCCP, HF-Cert, CDCES, AACC Clinical Pharmacist Practitioner LTC Charles S. Kettles VA Medical Center GET CE FOR THIS LISTENING! The GameChangers Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.   CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify recent guideline and practice updates that may influence the diagnosis, treatment, and monitoring of hypertension. 2. Discuss current and emerging tools Follow CEimpact on Social Media: LinkedIn Instagram

    48 min
  2. Alpha-Gal Syndrome and the Role of the Pharmacist

    30 MAR

    Alpha-Gal Syndrome and the Role of the Pharmacist

    Alpha-gal syndrome (AGS), a growing allergy linked to tick bites and mammalian meat exposure, is a condition pharmacists can’t afford to overlook. This course discusses the pathophysiology of the syndrome, common triggers, and emerging case trends—while highlighting how pharmacists can play a critical role in helping patients navigate safe OTC and prescription therapies by screening for allergenic excipients. You will gain practical knowledge to support patient education, ensure safe medication use, and guide appropriate referrals. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Geoff Wall, PharmD, BCPS Professor of Pharmacy Practice Drake University GET CE FOR THIS LISTENING! The GameChangers Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.   CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the pathophysiology, triggers, and clinical presentation of alpha‑gal syndrome. 2. Identify pharmacist‑led strategies for patient counseling, medication review, and referral when AGS is suspected or confirmed. Rachel Maynard and Geoff Wall have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-058-H01-P Initial release date: 3/30/2026 Expiration date: 3/30/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    33 min
  3. How AI is Reshaping Patient Care

    23 MAR

    How AI is Reshaping Patient Care

    Artificial intelligence (AI) is rapidly transforming the healthcare landscape—and pharmacy is no exception. This course explores emerging and potential uses of AI in pharmacy practice, including workflow automation, drug information access, and tools that support patient care and clinical decision-making. You will gain insight into practical considerations, limitations, and ethical responsibilities pharmacists must navigate as AI becomes more integrated into practice. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Timothy Aungst, PharmD Professor of Pharmacy Practice Massachusetts College of Pharmacy and Health Sciences GET CE FOR THIS LISTENING! The GameChangers Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.   CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify current and potential uses of AI that support pharmacist-led patient care services. 2. Describe considerations, limitations, and ethical concerns related to implementing AI tools in pharmacy practice. Rachel Maynard and Timothy Aungst have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-060-H04-P Initial release date: 3/23/2026 Expiration date: 3/23/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    35 min
  4. Second-Generation Antipsychotics as Adjunctive Therapy for Depression

    16 MAR

    Second-Generation Antipsychotics as Adjunctive Therapy for Depression

    Second-generation (also known as atypical) antipsychotics are increasingly used as adjunctive therapy for patients with major depressive disorder who have an inadequate or partial response to antidepressants. This course reviews the clinical rationale for their use, highlights newly approved options, and examines key safety, efficacy, and monitoring considerations. You will gain practical guidance to support patient selection, counseling, and shared decision-making when these agents are incorporated into depression management. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Sarah Grady, PharmD, BCPS, BCPP Professor of Pharmacy Practice, Clinical Pharmacist Drake University/Broadlawns Medical Center GET CE FOR THIS LISTENING! The GameChangers Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.   CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Explain the role of second-generation (atypical) antipsychotics as adjunctive therapy in the management of major depressive disorder. 2. Identify pharmacist-relevant considerations for counseling, monitoring, and risk benefit assessment when second-generation antipsychotics are used for depression. Rachel Maynard and Sarah Grady have no relevant financial relationships to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-059-H01-P Initial release date: 3/16/2026 Expiration date: 3/16/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    34 min
  5. Recent Updates on GLP-1 Therapies

    9 MAR

    Recent Updates on GLP-1 Therapies

    GLP‑1 receptor agonists continue to generate clinical and media buzz, with new formulations, new approvals, and expanding areas of research. This course explores key updates, including the FDA approval of the first oral GLP‑1 for chronic weight management and ongoing investigations into GLP‑1 therapies for conditions beyond diabetes and obesity. You will gain a timely overview of recent developments in GLP‑1s and how pharmacists can anticipate and support their evolving role in patient care. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Christine Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP Professor, Pharmacy Practice and Clinical Pharmacist Midwestern University GET CE FOR THIS LISTENING! The GameChangers Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize recent regulatory and clinical updates related to GLP‑1 receptor agonists, including new formulations. 2. Describe emerging areas of research into the use of GLP‑1 therapies beyond diabetes and obesity treatment. Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.  Christie Schumacher is a speaker for and is on the advisory board for Abbott. All relevant financial relationships have been mitigated. 0.1 CEU/1.0 Hr UAN: 0107-0000-26-081-H01-P Initial release date: 3/9/2026 Expiration date: 3/9/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    47 min
  6. Shared Clinical Decision-Making and the Pharmacist's Role

    2 MAR

    Shared Clinical Decision-Making and the Pharmacist's Role

    Recent changes to childhood vaccine recommendations have introduced shared clinical decision‑making for several immunizations that were previously universally recommended, creating confusion among patients and providers alike. This course explains what shared clinical decision‑making means in the context of immunizations, examines how it affects pediatric vaccine discussions, and highlights opportunities for pharmacists to support informed, individualized conversations with patients and caregivers. You will gain clarity on how to apply shared clinical decision‑making principles—alongside proven health coaching strategies—to strengthen patient trust and foster more meaningful dialogue in pharmacy practice. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Elizabeth Skoy, PharmD, RPh Professor North Dakota State University GET CE FOR THIS LISTENING! The GameChangers Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.   CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe shared clinical decision-making and how it applies to recent pediatric vaccine recommendations. 2. Identify the pharmacist's roles in counseling, education, and facilitating shared clinical decision-making conversations with patients and caregivers.  Rachel Maynard and Elizabeth Skoy have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-077-H01-P Initial release date: 3/2/2026 Expiration date: 3/2/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    44 min
  7. Balancing the Benefits and Risks of Gabapentin

    23 FEB

    Balancing the Benefits and Risks of Gabapentin

    As gabapentin climbs the ranks to become one of the most prescribed medications in the U.S., questions about its safety and scope of use are also rising. This episode explores recent trends in gabapentin use, highlights key patient safety concerns, and examines pharmacist-led opportunities to reduce risks through education and medication review. You will walk away with timely insights to help navigate the growing complexities and responsibilities associated with gabapentin use. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Nakia Duncan, PharmD BCGP, BCPS Associate Professor/ Pain& Palliative Care Clinical Pharmacist Texas Tech Health Science Center - School of Pharmacy GET CE FOR THIS LISTENING! The GameChangers Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Purchase the Clinical Update Series or this course individually to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.   CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize recent national prescribing trends and safety concerns associated with gabapentin use. 2. Identify pharmacist-led strategies to support safe use, patient education, and medication review involving gabapentin. Rachel Maynard and Nakia Duncan have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-053-H01-P Initial release date: 2/23/2026 Expiration date: 2/23/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    30 min
  8. Updates in HIV PEP Protocols and Guidelines

    16 FEB

    Updates in HIV PEP Protocols and Guidelines

    Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures — reflecting advances in antiretroviral therapy and evolving evidence. This course summarizes key changes, including preferred regimens, testing/follow‑up modifications, and special‑population considerations, and explores how these updates influence clinical practice. You will gain the practical knowledge needed to inform prompt PEP decision‑making, patient counseling, and care coordination. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Kenric Ware, Pharm D Clinical Associate Professor of Pharmacy Practice Mercer University GET CE FOR THIS LISTENING! The GameChangers Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.   CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify current guideline recommendations for initiating HIV PEP after occupational and non-occupational exposure. 2. Describe key considerations for selecting and managing HIV PEP regimens. Rachel Maynard and Kenric Ware have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-052-H01-P Initial release date: 2/16/2026 Expiration date: 2/16/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    41 min
See All (381)

About

The CEimpact Podcast features two shows:  GameChangers Clinical Updates  Precept2Practice GameChangers Clinical Update Series: The GameChangers podcast, hosted by Rachel Maynard, PharmD, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Listeners can purchase the episode to earn CE credit at: https://www.ceimpact.com/resources/podcast/  Precept2PracticeThe Precept2Practice podcast, hosted by Kathy Schott, brings you tools to mentor students and residents with confidence.  New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.Give us a follow, tune in regularly, and turn your drive time, coffee break, or chart review into a chance to level up your practice. CEimpact continuing education makes pharmacy learning inspiring!  Check back each week for our latest episodes. 

Information

  • Creator
    CEimpact
  • Years Active
    2021 - 2026
  • Episodes
    381
  • Rating
    Clean
  • Copyright
    © 2026 CEimpact Podcast
  • Show Website
    CEimpact Podcast

You Might Also Like